Is Ryman Healthcare Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Ryman Healthcare Limited pays dividends. Last time was Friday 16th of December 2022 where the investors holding the stock on Thursday 8th of December 2022 were paid NZD0.088 per share. Over the last 30 times between 2007 and 2022, Ryman Healthcare Limited has paid NZD2.1905 with an average of NZD0.07 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Ryman Healthcare Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was NZD13.30, you would have made a loss of NZD-8.68 per share or -65.26%
Yes, the average daily trading liquidity for Ryman Healthcare Limited is NZD1.21 million. You should therefore be able to get in and out of your positions relatively fast.
Ryman Healthcare Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.37, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 0.72%, which is challenging.
We have calculated the inflation risk for Ryman Healthcare Limited to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.